Table 2.
All patients (n = 213) | Lymph node involvement | p | |
---|---|---|---|
Positive (n = 60) | Negative (n = 153) | ||
Gender | 0.712 | ||
Female | 9 | 20 | |
Male | 51 | 133 | |
Age at surgery | 67 (51–85) | 66 (39–81) | 0.890 |
Tumor location | 0.338 | ||
Upper | 4 | 18 | |
Middle | 33 | 79 | |
Lower | 23 | 56 | |
Tumor size (mm) | 40 (10–95) | 35 (10–106) | 0.146 |
Tumor depth (pT) | < 0.0001* | ||
T1 | 29 | 123 | |
T2 | 7 | 10 | |
T3 | 22 | 18 | |
T4a | 2 | 0 | |
T4b | 0 | 2 | |
Lymph node metastasis (pN) | < 0.0001* | ||
N0 | 0 | 152 | |
N1 | 45 | 0 | |
N2 | 12 | 1 | |
N3 | 3 | 0 | |
Pathological stage | < 0.0001* | ||
IA | 1 | 109 | |
IB | 0 | 23 | |
IIA | 0 | 18 | |
IIB | 27 | 0 | |
IIIA | 23 | 1 | |
IIIB | 4 | 0 | |
IIIC | 5 | 2 | |
Tumor histology | 0.032* | ||
Squamous cell carcinoma | 49 | 141 | |
Adenocarcinoma | 5 | 6 | |
Other | 6 | 6 | |
Tumor differentiation of SCC | |||
G1 | 11 | 17 | 0.005* |
G2 | 23 | 101 | |
G3 | 15 | 21 | |
N/A | 0 | 2 | |
Prognosis | |||
Alive | 40 | 124 | 0.017* |
Deceased from esophageal ca. | 10 | 7 | |
Deceased from other ca. | 0 | 4 | |
Deceased from other diseases | 10 | 18 |
*Statistically significant